GO:0035783 CD4-positive, alpha-beta T cell costimulation: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035783 describes the antigen-independent second signal delivered by surface receptor-ligand pairs that augments activation of CD4-positive, alpha-beta T cells.
• Costimulation is essential for optimal CD4 T cell priming, cytokine production, and effector differentiation, and it shapes the balance between tolerance and immunity.
• Key costimulatory receptor-ligand pairs include CD28-B7 and CD134 (OX40)-CD134L, which cooperate with TCR signals to drive clonal expansion and survival.
• Dysregulated CD4 T cell costimulation contributes to autoimmune pathology, chronic infection, and tumor immune evasion, making it a target for immunotherapy.
• Human CD4+ alpha-beta T cell responses to pathogens such as Mycobacterium tuberculosis are modulated by costimulation and cytokines like IL-10 and TGF-beta.
• CRISPR knockout, knock-in, and overexpression models enable causal dissection of costimulatory genes in primary and immortalized CD4 T cells.
Description
CD4-positive, alpha-beta T cell costimulation (GO:0035783) is the process by which surface-bound receptor-ligand interactions provide a second, antigen-independent signal that augments T cell receptor (TCR)-driven activation of CD4+ alpha-beta T cells. This costimulatory signal is not antigen-specific but is required for full T cell priming, cytokine production, and effector function, and it helps determine whether a CD4 T cell becomes activated, anergic, or tolerized. The term is defined in QuickGO as the process of providing, via surface-bound receptor-ligand pairs, a second, antigen-independent signal in addition to that provided by the T cell receptor to augment CD4-positive, alpha-beta T cell activation. Researchers study GO:0035783 because it sits at the interface of adaptive immunity, autoimmunity, and cancer immunotherapy, and because costimulatory pathways are druggable targets for modulating T cell responses. Experimental systems ranging from TCR-transgenic T cells to human CD4+ T cell clones have been used to dissect the molecular requirements for costimulation. In this article, we integrate the QuickGO definition with verified PubMed literature to provide a research-grade overview of the mechanisms, key genes, disease relevance, and CRISPR-based methods used to study CD4-positive, alpha-beta T cell costimulation.
CD4-positive, alpha-beta T cell costimulation At A Glance
| GO ID | GO:0035783 |
|---|---|
| GO term | CD4-positive, alpha-beta T cell costimulation |
| Ontology | biological_process |
| Synonym | CD4-positive, alpha beta T cell costimulation |
| Definition | The process of providing, via surface-bound receptor-ligand pairs, a second, antigen-independent, signal in addition to that provided by the T cell receptor to augment CD4-positive, alpha-beta T cell activation. |
| Major function | Amplifies TCR signaling to promote CD4+ alpha-beta T cell activation, cytokine production, and effector differentiation. |
| Cellular context | Occurs at the T cell membrane during interaction with antigen-presenting cells or other costimulatory ligand-expressing cells. |
| Key receptor-ligand pairs | CD28-B7 and CD134 (OX40)-CD134L are well-characterized costimulatory pairs in CD4 T cells. |
| Disease relevance | Costimulation influences autoimmunity, chronic infection, and anti-tumor immunity. |
What Is GO:0035783?
GO:0035783 (CD4-positive, alpha-beta T cell costimulation) is a biological process in which surface-bound receptor-ligand pairs deliver a second, antigen-independent signal that enhances activation of CD4-positive, alpha-beta T cells. This costimulatory signal acts in addition to the primary TCR signal and is required for optimal T cell activation, proliferation, and effector differentiation.
Why Is CD4-positive, alpha-beta T cell costimulation Important in Cell Biology?
CD4-positive, alpha-beta T cell costimulation is critical because it determines the magnitude and quality of adaptive immune responses. Without costimulation, TCR engagement alone can lead to anergy or tolerance rather than productive immunity. Costimulatory signals shape CD4 T cell differentiation into Th1, Th2, Th17, and Tfh subsets, influence memory formation, and modulate responses to pathogens such as Mycobacterium tuberculosis. In disease, dysregulated costimulation can break tolerance and drive autoimmunity, while insufficient costimulation can impair pathogen clearance or anti-tumor immunity. Understanding GO:0035783 therefore has direct implications for vaccine design, checkpoint immunotherapy, and treatment of autoimmune diseases.
• Costimulation is required for optimal CD4 T cell priming and clonal expansion after antigen recognition.
• It prevents anergy and promotes T cell survival, cytokine production, and effector differentiation.
• CD28-B7 and CD134-CD134L are central costimulatory pathways in CD4+ alpha-beta T cells.
• Costimulation modulates human CD4+ T cell responses to Mycobacterium tuberculosis and other pathogens.
• Dysregulated costimulation contributes to autoimmune disease by breaking T cell tolerance.
• Costimulatory molecules are targets for cancer immunotherapy and autoimmune therapeutics.
• CD4+ alpha-beta T cell clones and lines are key tools for studying costimulation in vitro.
• Cytokines such as IL-10 and TGF-beta can regulate costimulation-dependent CD4 T cell responses.
• Costimulation influences T cell homeostasis and the balance between CD4 and CD8 T cell pools.
• CRISPR-based editing enables causal testing of costimulatory genes in primary and model T cells.
What Happens During CD4-positive, alpha-beta T cell costimulation?
TCR engagement and initial signal 1
In simple terms: First, the T cell receptor recognizes antigen, which is signal one.
CD4-positive, alpha-beta T cells first receive signal 1 through TCR recognition of peptide-MHC class II complexes on antigen-presenting cells. This antigen-specific signal alone is insufficient for full activation and can lead to anergy without a second signal. Studies using CD4+ alpha-beta T cell clones and lines have shown that TCR engagement triggers early signaling events that are then modulated by costimulation.
Delivery of the costimulatory signal 2
In simple terms: A second signal comes from surface receptor-ligand pairs, not from antigen.
Costimulation is provided by surface-bound receptor-ligand pairs that engage in trans between the T cell and the antigen-presenting cell. This signal is antigen-independent and augments TCR-driven activation. The CD28-B7 pathway is a canonical costimulatory axis, and CD134 (OX40)-CD134L costimulation has been shown to be important for optimal CD4 T cell priming after LPS-based adjuvanticity.
Intracellular signaling amplification
In simple terms: Inside the cell, costimulation boosts the biochemical signals started by the TCR.
Costimulatory receptors recruit adaptors and kinases that amplify TCR-proximal signaling, leading to sustained activation of transcription factors such as NF-kB, NFAT, and AP-1. This results in increased IL-2 production, CD25 expression, and cell cycle entry. The integration of signal 1 and signal 2 determines the threshold for full CD4 T cell activation.
Effector differentiation and cytokine production
In simple terms: The boosted signals push the T cell to become an active helper cell that makes cytokines.
Costimulation promotes differentiation of CD4+ alpha-beta T cells into effector subsets, including Th1, Th2, and Th17 cells, and enhances production of cytokines such as IFN-gamma and IL-2. Human CD4+ alpha-beta T cell clones are predominantly Th0-like and can produce multiple cytokines, and costimulation influences this cytokine profile. In Mycobacterium tuberculosis responses, costimulation together with cytokines like IL-10 and TGF-beta regulates CD4+ TCR+ T cell responses.
Regulation by the tissue microenvironment
In simple terms: The surroundings of the T cell can turn costimulation up or down.
The tissue microenvironment, including cytokines and adjuvants, modulates costimulatory requirements. For example, CXCL9 production is important for optimal CD4 T cell priming when CD134 costimulation is engaged after LPS-based adjuvanticity. Infection can break T cell tolerance, highlighting that inflammatory contexts can override or alter costimulatory checkpoints. B7 costimulation also influences CD4/CD8 T cell homeostasis, showing that costimulatory signals have systemic effects beyond acute activation.
Key Genes Involved in GO:0035783 CD4-positive, alpha-beta T cell costimulation
The following genes and proteins are central to CD4-positive, alpha-beta T cell costimulation, based on verified literature and their established roles in T cell activation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CD28 | Canonical costimulatory receptor on T cells binding B7 ligands | Target for knockout and knock-in studies of costimulation |
| CD80 (B7-1) | Ligand for CD28 and CTLA-4 on antigen-presenting cells | Studied in B7 costimulation and T cell homeostasis |
| CD86 (B7-2) | Ligand for CD28 and CTLA-4 on antigen-presenting cells | Key in CD4/CD8 T cell homeostasis |
| CD134 (OX40) | Costimulatory receptor promoting CD4 T cell priming and survival | Required for optimal CD4 T cell priming with LPS adjuvanticity |
| CD134L (OX40L) | Ligand for CD134 on antigen-presenting cells | Studied in costimulation-dependent CXCL9 production |
| TCR alpha chain (TRAC) | Part of the alpha-beta TCR recognizing peptide-MHC | Defines the alpha-beta T cell lineage in costimulation studies |
| TCR beta chain (TRBC) | Part of the alpha-beta TCR recognizing peptide-MHC | Used to identify alpha-beta T cells in functional assays |
| CD4 | Coreceptor for MHC class II, defining CD4+ T cells | Marker for CD4-positive, alpha-beta T cell costimulation |
| CD8 alpha | Coreceptor for MHC class I; can be co-expressed in some CD4+ T cells | Studied in CD4+ TCR alpha beta+ T cells in intestinal epithelium |
| IL2 | T cell growth factor produced after costimulation | Readout of costimulation-dependent activation |
| IFNG | Effector cytokine produced by Th1 CD4 T cells | Measured in costimulation and infection studies |
| IL10 | Regulatory cytokine modulating CD4 T cell responses | Regulates human CD4+ TCR+ T cell responses to M. tuberculosis |
| TGFB1 | Regulatory cytokine modulating T cell responses | Regulates CD4+ TCR+ T cell responses to M. tuberculosis |
| CXCL9 | Chemokine involved in T cell priming | Required for optimal CD4 T cell priming with CD134 costimulation |
| CTLA4 | Inhibitory receptor competing with CD28 for B7 ligands | Regulates costimulation and T cell homeostasis |
| FOXP3 | Transcription factor for regulatory T cells | Relevant to tolerance and costimulation balance |
| CD25 (IL2RA) | High-affinity IL-2 receptor alpha chain | Marker of costimulation-driven activation |
How Is CD4-positive, alpha-beta T cell costimulation Regulated?
CD4-positive, alpha-beta T cell costimulation is regulated at multiple levels. The availability of costimulatory ligands on antigen-presenting cells, the expression of receptors such as CD28 and CD134 on T cells, and the presence of inhibitory receptors like CTLA-4 all set the threshold for activation. Cytokines in the microenvironment, including IL-10 and TGF-beta, can suppress costimulation-dependent CD4+ TCR+ T cell responses, as shown in human Mycobacterium tuberculosis studies. Adjuvants such as LPS can enhance CD134-dependent costimulation and CXCL9 production, linking innate signals to adaptive costimulation. Infection can also break T cell tolerance, indicating that inflammatory signals can override regulatory checkpoints. Together, these layers of regulation ensure that CD4 T cell activation occurs only in appropriate contexts.
CD4-positive, alpha-beta T cell costimulation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CD28 | Autoimmunity and cancer immunotherapy | CD28 knockout or knock-in in primary CD4 T cells |
| CD134 (OX40) | Enhanced CD4 T cell priming in infection and cancer | CD134 knockout mice or CRISPR KO in T cell lines |
| IL10 | Regulation of M. tuberculosis-specific CD4 T cell responses | IL10 knockout or overexpression in human CD4 T cell cultures |
| TGFB1 | Suppression of CD4+ TCR+ T cell responses in infection | TGFB1 knockout or knockdown in T cell assays |
| CXCL9 | Chemokine-dependent CD4 T cell priming | CXCL9 knockout or overexpression in APC-T cell cocultures |
Autoimmunity and loss of tolerance
Costimulation is a key checkpoint that maintains T cell tolerance. Infection can break T cell tolerance, leading to activation of autoreactive T cells and autoimmune pathology. Dysregulated CD28-B7 costimulation can lower the threshold for CD4 T cell activation and contribute to autoimmune diseases. Understanding GO:0035783 is therefore central to developing therapies that restore tolerance.
Chronic infection and pathogen-specific immunity
Human CD4+ alpha-beta T cell responses to Mycobacterium tuberculosis are modulated by costimulation and by cytokines such as IL-10 and TGF-beta. Optimal CD4 T cell priming after LPS-based adjuvanticity with CD134 costimulation relies on CXCL9 production, linking costimulation to chemokine-dependent immunity. Impaired costimulation can lead to inadequate pathogen control, while excessive costimulation can cause immunopathology.
Cancer immunotherapy
Costimulatory pathways are targets for cancer immunotherapy because they can enhance anti-tumor T cell responses. B7 costimulation influences CD4/CD8 T cell homeostasis, which affects the balance of effector and regulatory T cells in tumors. Agonist antibodies against costimulatory receptors such as CD134 are being explored to boost CD4 T cell help in anti-tumor immunity.
From CD4-positive, alpha-beta T cell costimulation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is CD28 required for CD4 T cell costimulation? | CD28 knockout in primary mouse or human CD4 T cells |
| Does CD134 costimulation enhance CD4 T cell priming? | CD134 knockout or agonist antibody treatment in mouse models |
| What is the role of CXCL9 in costimulation-dependent priming? | CXCL9 knockout or overexpression in APC-T cell cocultures |
| How does IL-10 regulate human CD4+ TCR+ T cell responses? | IL10 knockout or overexpression in human PBMC cultures |
| Can costimulation break T cell tolerance? | Infection models in TCR-transgenic mice |
| What is the effect of B7 costimulation on T cell homeostasis? | B7 knockout or transgenic overexpression in mice |
How to Study the CD4-positive, alpha-beta T cell costimulation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry | Surface and intracellular protein expression | Measure CD25, CD69, IFN-gamma after costimulation |
| CFSE dilution | Cell division and proliferation | Quantify costimulation-driven CD4 T cell expansion |
| ELISA | Cytokine secretion | Measure IL-2, IFN-gamma in culture supernatants |
| Coculture assays | T cell-APC interactions | Test costimulatory ligand requirements |
| CRISPR knockout | Gene function loss | Test requirement of CD28, CD134, CXCL9 |
| RNA-seq | Transcriptional changes | Identify costimulation-induced gene programs |
| Intracellular signaling assays | Phosphorylation of signaling proteins | Assess TCR-proximal signal amplification |
Flow cytometry and cytokine assays
Flow cytometry is used to measure activation markers such as CD25 and CD69, and intracellular cytokine staining for IFN-gamma and IL-2 provides a readout of costimulation-dependent CD4 T cell activation. These methods are standard for assessing GO:0035783 in vitro.
T cell proliferation and CFSE dilution
CFSE labeling and dilution assays quantify costimulation-driven proliferation of CD4+ alpha-beta T cells. This approach has been used to study B7 costimulation and CD4/CD8 T cell homeostasis.
Coculture with antigen-presenting cells
Coculture systems with dendritic cells or other APCs expressing costimulatory ligands allow dissection of receptor-ligand pairs. LPS-based adjuvanticity and CD134 costimulation have been studied in such systems.
CRISPR-Cas9 gene editing in T cells
CRISPR-Cas9 knockout of costimulatory genes in primary CD4 T cells or T cell lines enables causal testing of their role in GO:0035783. Knock-in of tagged or mutant receptors allows structure-function studies.
How CRISPR Can Be Used to Study GO:0035783 CD4-positive, alpha-beta T cell costimulation
Knockout
CRISPR knockout of costimulatory genes such as CD28, CD134, or CXCL9 in primary CD4 T cells or T cell lines can determine whether they are required for costimulation-dependent activation, proliferation, and cytokine production. Knockout models are also useful for testing redundancy among costimulatory pathways.
Point Mutation
Point mutations can be introduced into costimulatory receptors to dissect signaling motifs. For example, mutating tyrosine residues in the cytoplasmic domain of CD28 can reveal their role in recruiting PI3K and GRB2, thereby linking specific residues to GO:0035783.
Knock-in
Knock-in of tagged or fluorescently labeled costimulatory receptors allows tracking of receptor expression, localization, and interaction partners in live CD4 T cells. This approach can be combined with reporter knock-ins for cytokines such as IL-2 to monitor costimulation outcomes.
Overexpression
Overexpression of costimulatory ligands such as CD80 or CD86 on APCs, or of receptors such as CD134 on T cells, can enhance costimulation and is useful for studying gain-of-function effects in autoimmune and anti-tumor models.
How EDITGENE Supports CD4-positive, alpha-beta T cell costimulation Research
Researchers studying CD4-positive, alpha-beta T cell costimulation-related genes often need to determine whether a candidate gene is causally involved in T cell activation, differentiation, or tolerance. EDITGENE provides CRISPR-based cell model services that enable precise knockout, point mutation, knock-in, and overexpression of costimulatory genes in relevant T cell and APC backgrounds.
Contact EDITGENE today to design your custom CRISPR model for CD4-positive, alpha-beta T cell costimulation research.
Frequently Asked Questions About CD4-positive, alpha-beta T cell costimulation
What is CD4-positive, alpha-beta T cell costimulation?
It is the process by which surface-bound receptor-ligand pairs provide a second, antigen-independent signal that augments activation of CD4-positive, alpha-beta T cells, as defined by GO:0035783.
What genes are involved in CD4-positive, alpha-beta T cell costimulation?
Key genes include CD28, CD80, CD86, CD134 (OX40), CD134L, CXCL9, IL2, IFNG, IL10, and TGFB1, among others.
Why is costimulation important for CD4 T cells?
Costimulation is required for optimal CD4 T cell priming, cytokine production, and effector differentiation, and it prevents anergy.
What is the difference between signal 1 and signal 2 in T cell activation?
Signal 1 is TCR recognition of peptide-MHC, while signal 2 is antigen-independent costimulation delivered by receptor-ligand pairs such as CD28-B7.
How does CD28 costimulation work?
CD28 binds B7 ligands (CD80/CD86) on antigen-presenting cells and amplifies TCR signaling to promote IL-2 production and T cell proliferation.
What is the role of CD134 (OX40) in CD4 T cell costimulation?
CD134 costimulation enhances CD4 T cell priming and survival, and it relies on CXCL9 production in some adjuvant contexts.
How do IL-10 and TGF-beta regulate CD4 T cell costimulation?
IL-10 and TGF-beta can suppress human CD4+ TCR+ T cell responses, modulating costimulation-dependent activation in infection.
Can infection break T cell tolerance through costimulation?
Yes, infection can break T cell tolerance, leading to activation of autoreactive T cells.
What experimental models are used to study CD4 T cell costimulation?
Models include CD4+ alpha-beta T cell clones, TCR-transgenic mice, knockout mice, and CRISPR-edited primary T cells.
How can CRISPR be used to study CD4-positive, alpha-beta T cell costimulation?
CRISPR knockout, knock-in, point mutation, and overexpression can be used to test the causal role of costimulatory genes in T cell activation.
Conclusion
GO:0035783 (CD4-positive, alpha-beta T cell costimulation) is a central biological process that integrates antigen-independent signals to shape CD4+ alpha-beta T cell activation, differentiation, and tolerance. Its dysregulation contributes to autoimmunity, chronic infection, and cancer, making it a high-value target for immunotherapy and vaccine design. CRISPR-based models from EDITGENE provide a robust path to dissect the causal roles of costimulatory genes and to accelerate translational research in this field.
References
- 1. Shinde P et al.. 2017. Optimal CD4 T cell priming after LPS-based adjuvanticity with CD134 costimulation relies on CXCL9 production.. J Leukoc Biol 102(1):57-69 PMID: 28432083
- 2. Katsikis PD et al.. 1995. Human alpha beta T-cell receptor CD4-CD8 T-cell clones are predominantly Th0-like.. Immunology 84(4):501-4 PMID: 7790021
- 3. Tsukaguchi K et al.. 1995. CD4+ alpha beta T cell and gamma delta T cell responses to Mycobacterium tuberculosis. Similarities and differences in Ag recognition, cytotoxic effector function, and cytokine production.. J Immunol 154(4):1786-96 PMID: 7836763
- 4. Yu X et al.. 2000. The role of B7 costimulation in CD4/CD8 T cell homeostasis.. J Immunol 164(7):3543-53 PMID: 10725709
- 5. Sydora BC et al.. 1991. Characterization of a CD4-positive T-cell line derived from an athymic (nu/nu) mouse.. Cell Immunol 134(1):54-64 PMID: 1707347
- 6. Röcken M et al.. 1992. Infection breaks T-cell tolerance.. Nature 359(6390):79-82 PMID: 1355854
- 7. Reimann J et al.. 1995. Co-expression of CD8 alpha in CD4+ T cell receptor alpha beta + T cells migrating into the murine small intestine epithelial layer.. Eur J Immunol 25(6):1580-8 PMID: 7614985
- 8. Rojas RE et al.. 1999. Regulation of human CD4(+) alphabeta T-cell-receptor-positive (TCR(+)) and gammadelta TCR(+) T-cell responses to Mycobacterium tuberculosis by interleukin-10 and transforming growth factor beta.. Infect Immun 67(12):6461-72 PMID: 10569764
